88639660 - ONCOTYPE DXX

Information

  • Trademark
  • 88639660
  • Serial Number
    88639660
  • Filing Date
    October 02, 2019
    4 years ago
  • Transaction Date
    February 16, 2021
    3 years ago
  • Status Date
    February 15, 2021
    3 years ago
  • Published for Opposition Date
    May 19, 2020
    4 years ago
  • Location Date
    July 14, 2020
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CHOSID, ROBIN S
  • Attorney Name
    Sana Hakim
    Law Office Assigned Location Code
    L20
  • Owners
Mark Drawing Code
4000
Mark Identification
ONCOTYPE DXX
Case File Statements
  • GS0011: Assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; clinical diagnostic reagents
  • GS0051: Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical diagnostic purposes consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for medical purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer for medical purposes; diagnostic agents, preparations and substances for medical purposes
  • GS0421: Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification
  • GS0441: Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
  • PM0001: ONCO TYPE DXX
Case File Event Statements
  • 2/16/2021 - 3 years ago
    22 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 2/15/2021 - 3 years ago
    21 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/14/2020 - 3 years ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/19/2020 - 3 years ago
    19 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/19/2020 - 3 years ago
    18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/19/2020 - 3 years ago
    17 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/19/2020 - 3 years ago
    16 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/19/2020 - 3 years ago
    15 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 5/19/2020 - 4 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/19/2020 - 4 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/29/2020 - 4 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/15/2020 - 4 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/14/2020 - 4 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/14/2020 - 4 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/9/2020 - 4 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 4/1/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/18/2019 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/18/2019 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/18/2019 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/11/2019 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/6/2019 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 10/5/2019 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP